CME Group Inc. (NASDAQ:CME) Shares Sold by Inscription Capital LLC

Inscription Capital LLC lessened its holdings in shares of CME Group Inc. (NASDAQ:CME) by 4.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,073 shares of the financial services provider’s stock after selling 104 shares during the period. Inscription Capital LLC’s holdings in CME Group were worth $457,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CME. Oak Harvest Investment Services increased its stake in CME Group by 66.5% in the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after purchasing an additional 18,017 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after buying an additional 8,443 shares during the last quarter. Duality Advisers LP acquired a new stake in CME Group during the 1st quarter worth $1,455,000. SG Americas Securities LLC lifted its position in CME Group by 312.2% in the first quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after acquiring an additional 42,996 shares during the last quarter. Finally, Cetera Investment Advisers boosted its stake in CME Group by 429.1% in the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after acquiring an additional 38,540 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on CME shares. Piper Sandler boosted their target price on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday. Keefe, Bruyette & Woods boosted their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. The Goldman Sachs Group upped their price target on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Finally, Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research report on Tuesday, October 8th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Stock Up 0.9 %

CME opened at $228.12 on Tuesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The stock has a market capitalization of $82.14 billion, a P/E ratio of 25.95, a P/E/G ratio of 7.76 and a beta of 0.55. The business has a 50 day simple moving average of $219.32 and a 200-day simple moving average of $208.98.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the company earned $2.25 earnings per share. CME Group’s quarterly revenue was up 18.4% compared to the same quarter last year. On average, equities analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.02%. CME Group’s payout ratio is currently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.